Cancer incidence in a general population of asthma patients

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 2, 2006, Pages 131-138

  González Pérez, Antonio ^a,c   Fernández Vidaurre, Carlos ^b   Rueda, Ana ^b   Rivero, Elena ^b   García Rodríguez, Luis A ^a  

^a Centro Español de Investigación Farmacoepidemiológica ^*  (Spain)

^b Novartis Farmacéutica S A   (Spain)

^c NONE   (Spain)

Author keywords

Asthma; Epidemiologic studies; Neoplasms

Indexed keywords

AMINOPHYLLINE; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RESPIRATORY TRACT AGENT; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; BREAST CANCER; CANCER; CANCER INCIDENCE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG USE; ESOPHAGUS CANCER; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; SMOKING; STOMACH CANCER; UNITED KINGDOM;

EID: 33644630456     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1163     Document Type: Article

References (49)

1. Haahtela T, Heiskala M, Suoniemi I. Allergic disorders and immediate skin test reactivity in Finnish adolescents. Allergy 1980; 35: 433-441.
2. Kiviloog J, Irnell L, Eklund G. The prevalence of bronchial asthma and chronic bronchitis in smokers and non-smokers in a representative local Swedish population. Scand J Respir Dis 1974; 55: 262-276.
3. Alderson M. Mortality from malignant disease in patients with asthma. Lancet 1974; 2: 1475-1477.
4. Allegra J, Lipton A, Harvey H, et al. Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res 1976; 36: 3225-3226.
5. Cockcroft D, Klein G, Donevan R, et al. Is there a negative correlation between malignancy and respiratory atopy? Ann Allergy 1979; 43: 345-347.
6. Fisherman E. Does the allergic diathesis influence malignancy? J Allergy 1960; 1: 74-78.
7. Gabriel R, Dudley B, Alexander W. Lung cancer and allergy. Br J Clin Pract 1972; 26: 202-204.
8. Ford R. Primary lung cancer and allergy. Ann Allergy 1978; 49: 240-242.
9. Hughes W, Raitz R. A comparison of cancer occurrence in allergic and non-allergic populations. Ann Allergy 1979; 43: 163-164.
10. Johnson K. The relation of cancer to allergy. Lancet 1966; 86: 5-11.
11. Kallen B, Gunnarskog J, Conradson T-B. Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 1993; 6: 694-697.
12. Mackay W. The incidence of allergic disorders and cancer. Br J Cancer 1966; 20: 434-437.
13. McDuffie H. Atopy and primary lung cancer: histology and sex distribution. Chest 1991; 99: 404-407.
14. Rozencwaig R. Allergies: protective against cancer but predisposing to heart disease. (Letter). Postgrad Med 1982; 72: 42.
15. Severson R, Davis S, Thomas D, et al. Acute myelocytic leukemia and prior allergies. J Clin Epidemiol 1989; 42: 995-1001.
16. Ure D. Negative associations between allergy and cancer. Scott Med J 1969; 14: 51-54.
17. Vena J, Bona J, Byers T, et al. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 1985; 122: 66-74.
18. Bernard S, Cartwright R, Bird C, et al. Etiological factors in lymphoid malignancies: a case-control epidemiological study. Leuk Res 1984; 8: 681-689.
19. Gallagher R, Spinelli J, Elwood J, et al. Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer 1983; 48: 853-857.
20. Logan J, Saker D. The incidence of allergic disorders in cancer. N Z Med J 1953; 52: 210-212.
21. McWorter W. Allergy and risk of cancer: a prospective study using NHANES I follow up data. Cancer 1988; 62: 451-455.
22. Robinette C, Fraumeni J Jr. Asthma and subsequent mortality in World War H veterans. J Chronic Dis 1978; 31: 619-624.
23. Johnson KJ. The relation of cancer to allergy. Lancet 1966; 86: 5-11.
24. Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99: 252-259.
25. Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999; 82: 155-160.
26. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002; 98: 609-615.
27. Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 2003; 158: 432-441.
28. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999; 80: 1830-1837.
29. Holly EA, Lele C. Non-Hodgkin's lyrnphorna in HIV-positive and HIV-negative homosexual men in the Sari Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Inumme Defic Syndr Hwn Retrovirol 1997; 15: 211-222.
30. Schuz J, Morgan G, Bohler E, et al. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer 2003; 105: 255-260.
31. Vesterinen E, Pukkala E, Timonen T, et al. Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 1993; 22: 976-982.
32. Wen W, Shu XO, Linet MS, et al. Allergic disorders and the risk of childhood acute lymphoblastic leukemia (United States). Cancer Causes Control. 2000; 11: 303-307.
33. Santillan A, Camargo C Jr, Colditz G. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003; 14: 327-334.
34. Reynolds P, Kaplan GA. Asthma and cancer. Am J Epidemiol 1987; 125: 539-540.
35. Eriksson NE, Holmen A, Hogstedt B, et al. Prospective study of cancer incidence in a cohort examined for allergy. Allergy 1995; 50: 718-722.
36. Mills PK, Beeson WL, Fraser GE, et al. Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 1992; 136: 287-295.
37. Talbot-Smith A, Fritschi L, Divitini ML, et al. Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003; 157: 606-612.
38. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 199 1; 302: 766-768.
39. Hansell A, Hollowell J, Nichols T, et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th morbidity survey in general practice (MSGP4). Thorax 1999; 54: 413-419.
40. Lanes S, García Rodríguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002; 57: 683-686.
41. Rothman KJ, Greenland S. Introduction to stratified analysis. In Modem Epidemiology (2nd edn) Rothman Kenneth J, Greenland Sander (eds). Lippincott-Raven Publishers: Boston, 1998: 260.
42. World Health Organization. GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide, IARC Cancerbase No. 5, Version 1.0. Lyon: IARC, 2001.
43. Eisner MD. Environmental tobacco smoke and adult asthma. Clin Chest Med 2002; 23: 749-761.
44. Cherickh WS, Kauffman HM, McBride MA, et al. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003; 76: 1289-1293.
45. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222-230.
46. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913.
47. Bustarni RT, Ojo AO, Wolfe A, et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004; 4: 87-93.
48. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic Countries, 1964-1986. Int J Cancer 1995; 60: 183-189.
49. Sorensen HT, Mellemkjaer L, Nielsen GL, et al. Skin cancers and non-Hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 2004; 96: 709-711.